Immunoselect® is produced by using the E. angustifolia roots harvested in the US.
Immunoselect® is standardized to contain at least 4% of echinacoside, the major polyphenols in E. angustifolia root, based on HPLC analysis according to USP, and is containing Isobutylamides with activity show anti-inflammatory and pain relief action.root, based on HPLC analysis according to USP, and is containing Isobutylamides with activity show anti-inflammatory and pain relief action.
Echinacea angustifolia DC.
≥4.0% of echinacoside by HPLC
Please note this website is accessible from various countries all over the world and hence it may contain statements or product classification not applicable to your country. The claims made are in reference to ingredients only, therefore they do not refer to finished products and they may not comply with Regulation 1924/2006/CE. The marketer of any finished product containing any ingredient is responsible for assuring that the destination of the product and the claims made for the finished product are lawful and comply with all applicable laws and regulations of the country or countries in which the product is to be sold.